This Article Full Text (PDF) Correction (v54,p859) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, H. Articles by Van Meir, E. G. Search for Related Content PubMed PubMed Citation Articles by Li, H. Articles by Van Meir, E. G.

Variant CD44 Adhesion Molecules Are Expressed in Human Brain Metastases but not in Glioblastomas¹

Laboratory of Tumor Biology and Genetics, Service of Neurosurgery, University Hospital (CHUV), CH-1011 Lausanne, Switzerland [H. L., M-F. H., N. d. T., R. J., A-C. D., E. G. V. M.], and Abteilung für Tumorprogression, Deutsches Krebsforschungszentrum, D-6900 Heidelberg, Germany [M. H.]

Although human glioblastomas are highly invasive tumors intracerebrally, only rarely do they metastasize outside the central nervous system. In contrast, the brain is a major target for metastatic spread of many systemic tumors. Recently, it was demonstrated that expression of splice variants of CD44 (CD44v), but not standard CD44 (CD44s), was sufficient to confer metastatic potential to low- or nonmetastatic rat tumor cells. Because CD44 is expressed in brain tumors, we examined whether differential expression of CD44 isoforms was correlated with the metastatic behavior of these tumors. We compared CD44s and CD44v expression in 17 human glioblastomas, 18 glioma cell lines, and metastases of 15 other tumors to the brain by reverse transcription/polymerase chain reaction, Northern blotting, and immunocytochemistry. These experiments showed that 0 of 17 glioblastomas and 0 of 18 glioma cell lines expressed CD44v as compared to 12 of 15 brain metastases. These data show a correlation between CD44v expression and the metastatic ability of the tumors analyzed (P < 0.01). This suggests (a) that the biological significance of the lack of CD44v expression in human glioblastomas warrants further examination with regard to their inability to metastasize extraneurally and (b) that CD44v expression may play a role in the intracerebral spread of about one-half of the brain metastases. Therefore, CD44v expression should be further considered as a potential marker for differential diagnosis and prognosis of patients with brain metastases.

¹ This work was supported by Grant 3.595.087 of the Swiss National Science Foundation to N. d. T.

² To whom requests for reprints should be addressed, at Laboratory of Tumor Biology and Genetics, Service of Neurosurgery, University Hospital (CHUV) rue du Bugnon 5, CH-1011 Lausanne, Switzerland.

Received 7/21/93. Accepted 10/ 5/93.

This article has been cited by other articles:

				Y. Xie, H. Chan, J. Fan, Y. Chen, J. Young, W. Li, X. Miao, Z. Yuan, H. Wang, P. K.H. Tam, et al. Involvement of visinin-like protein-1 (VSNL-1) in regulating proliferative and invasive properties of neuroblastoma Carcinogenesis, October 1, 2007; 28(10): 2122 - 2130. [Abstract] [Full Text] [PDF]

				I. Okamoto, H. Tsuiki, L. C. Kenyon, A. K. Godwin, D. R. Emlet, M. Holgado-Madruga, I. S. Lanham, C. J. Joynes, K. T. Vo, A. Guha, et al. Proteolytic Cleavage of the CD44 Adhesion Molecule in Multiple Human Tumors Am. J. Pathol., February 1, 2002; 160(2): 441 - 447. [Abstract] [Full Text] [PDF]

				C. L. Nutt, R. T. Matthews, and S. Hockfield Glial Tumor Invasion: A Role for the Upregulation and Cleavage of BEHAB/Brevican Neuroscientist, April 1, 2001; 7(2): 113 - 122. [Abstract] [PDF]

				Y. Ohene-Abuakwa and M. Pignatelli Adhesion Molecules as Diagnostic Tools in Tumor Pathology International Journal of Surgical Pathology, July 1, 2000; 8(3): 191 - 200. [Abstract] [PDF]

				L. Rodriguez-Rodriguez, I. Sancho-Torres, D. G. Gibbon, L. F. Miller Watelet, and C. Mesonero CD44-9v and CD44-10v Are Potential Molecular Markers for Squamous Cell Carcinoma of the Vulva Reproductive Sciences, January 1, 2000; 7(1): 70 - 75. [Abstract] [PDF]

				R. Ristamaki, H. Joensuu, K. Lappalainen, L. Teerenhovi, and S. Jalkanen Elevated Serum CD44 Level Is Associated With Unfavorable Outcome in Non-Hodgkin's Lymphoma Blood, November 15, 1997; 90(10): 4039 - 4045. [Abstract] [Full Text] [PDF]